An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...
A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...
The new study, published in The Lancet, is the first to evaluate a once-yearly injection of an HIV pre-exposure prophylaxis ...
A Lancet study shows promising results for an annual HIV prevention injection, lenacapavir. In Stage 1 trials, 40 HIV-negative participants had no significant side effects ...
A yearly injection to protect against HIV is safe and shows promise as a prevention method with long-lasting effects, according to the results of a c ...
SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company")(NYSE American:NNVC), a clinical-stage global ...
Dropping everything-or being forced to-for COVID-19 had widespread effects. On this fifth anniversary of the pandemic, three ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...
Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback